Quanterix (QTRX) is shedding several executives at its newly acquired subsidiary, Akoya Biosciences, as part of a cost-saving initiative expected to generate $2.8 million in annualized cash savings.
Severance-related expenses will be $3.3 million, the company said Friday in a regulatory filing.
Quanterix shares rose 5.4% in after-hours trading.